Identification, Assessment & Prevention of Adverse Drug Reactions

At Keron Lifesciences, we are committed to patient safety and the continuous monitoring of our pharmaceutical products throughout their lifecycle. Pharmacovigilance is a critical public health responsibility, aimed at identifying, evaluating, and preventing adverse drug reactions (ADRs) associated with the use of our medicines.

An Adverse Drug Reaction is any unintended, harmful response that may occur following the administration of a medicinal product under normal conditions of use.

Ensuring the safe use of our products requires close collaboration between pharmaceutical companies, healthcare professionals, regulatory authorities, and patients. At Keron, we maintain a robust pharmacovigilance system to uphold this responsibility.

Our Pharmacovigilance Activities Include:

• Prompt collection and assessment of adverse drug reaction reports

• Ongoing monitoring and evaluation of product safety profiles

• Timely communication with health authorities and implementation of risk mitigation measures

• Commitment to regulatory compliance in all pharmacovigilance activities

Reporting an Adverse Drug Reaction

If you or someone under your care has experienced a suspected adverse reaction to a Keron Lifesciences product, we encourage you to report it through one of the following methods:

• Call Us: ADR Helpline – [Insert Your Number]
  Available Monday to Friday, 9:00 AM to 6:00 PM

• Online Form Submission:
  [Click here to report an ADR online] (Link to be updated when available)

• Download & Submit Form by Post or Email:
  You may download the ADR reporting form and send the completed form to the address or email below:

Keron Lifesciences – Pharmacovigilance Department
D-5, Sara Industrial Estate, Rampur, Dehradun 248197 (Uttarakhand), INDIA.
Email: info@keronlifesciences.com